Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875

Validation of a combined comorbidity index

Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427

Regression modelling strategies for improved prognostic prediction

Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717

The pre-therapeutic classification of co-morbidity in chronic disease

Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386

Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission

Versluis, J., Kalin, B., Zeijlemaker, W., Passweg, J. R., Graux, C., Manz, M. G., Vekemans, M., Biemond, B. J., Legdeur, M. C. J. C., Kooy, M. V. M., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00078 · Cited by 37

Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients

Polverelli, N., Tura, P., Battipaglia, G., Malagola, M., Bernardi, S., Gandolfi, L., Zollner, T., Zanaglio, C., Farina, M., Morello, E., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0934-1 · Cited by 37

Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia

Dhakal, P., Shostrom, V., Al-Kadhimi, Z. S., Maness, L. J., Gundabolu, K., & Bhatt, V. R. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.07.002 · Cited by 37

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT

Shouval, R., Fein, J. A., Cho, C., Avecilla, S. T., Ruiz, J. D., Tomás, A. A., Sánchez‐Escamilla, M., Castillo, N., Yáñez, L., Barker, J. N., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004319 · Cited by 37

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia

Konuma, T., Mizuno, S., Kondo, T., Arai, Y., Uchida, N., Takahashi, S., Tanaka, M., Kuriyama, T., Miyakoshi, S., Onizuka, M., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00678-6 · Cited by 37

A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants

Hemmati, P., Terwey, T. H., le Coutre, P., Vuong, L. G., Massenkeil, G., Dörken, B., & Arnold, R. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01580.x · Cited by 37

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit

Mokart, D., Granata, A., Crocchiolo, R., Sannini, A., Chow‐Chine, L., Brun, J. P., Bisbal, M., Faucher, M., Faucher, C., Blache, J. L., et al. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.06.020 · Cited by 37

Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation

Sakellari, I., Mallouri, D., Gavriilaki, E., Batsis, I., Kaliou, M., Constantinou, V., Papalexandri, A., Lalayanni, C., Vadikolia, C., Athanasiadou, A., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.11.023 · Cited by 37

Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022

Roloff, G. W., Odenike, O. M., Bajel, A. R., Wei, A. H., Foley, N. C., & Uy, G. L. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349605 · Cited by 36

Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma

Caram, M. E. V., Bellile, E. L., Englesbe, M. J., Terjimanian, M. N., Wang, S. C., Griggs, J. J., & Couriel, D. R. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1014359 · Cited by 36

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

Oudin, C., Chevallier, P., Fürst, S., Guillaume, T., Cheikh, J. E., Delaunay, J., Castagna, L., Faucher, C., Granata, A. R. M., Devillier, R., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.105981 · Cited by 36

Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia

Tischer, J., Stemmler, H., Engel, N., Hubmann, M., Fritsch, S. M., Prevalšek, D., Schulz, C. U., Zoellner, A., Bücklein, V., Hill, W., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1862-6 · Cited by 36

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults

Sorror, M. L., & Estey, E. H. (2014) · Hematology · doi:10.1182/asheducation-2014.1.21 · Cited by 36

A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

Sauter, C. S., Barker, J. N., Lechner, L., Zheng, J., Devlin, S. M., Papadopoulos, E. B., Perales, M., Jakubowski, A. A., Goldberg, J. D., Koehne, G., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.11.029 · Cited by 36

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA‐identical sibling donor allogeneic hematopoietic cell transplantation

Hamilton, B. K., Rybicki, L. A., Dean, R. M., Majhail, N. S., Haddad, H., Abounader, D., Hanna, R., Sobecks, R. M., Duong, H., Hill, B. T., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23882 · Cited by 36

Novel therapeutic options in Acute Myeloid Leukemia

Medinger, M., Lengerke, C., & Passweg, J. R. (2016) · Leukemia Research Reports · doi:10.1016/j.lrr.2016.09.001 · Cited by 36

Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia

Wass, M., Hitz, F., Schaffrath, J., Müller‐Tidow, C., & Müller, L. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164587 · Cited by 36

Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival

El-Ghammaz, A. M. S., Matoug, R. B., El-Zimaity, M., & Mostafa, N. N. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3716-6 · Cited by 36

CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide

Mussetti, A., Philippis, C. D., Carniti, C., Bastos‐Oreiro, M., Gayoso, J., Cieri, N., Pennisi, M., Ciceri, F., Greco, R., Peccatori, J., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0183-8 · Cited by 36

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

Kongtim, P., Parmar, S., Milton, D. R., Perez, J. M. R., Rondón, G., Chen, J. J., Chilkulwar, A. R., Alatrash, G., Alousi, A. M., Andersson, B. S., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0344-9 · Cited by 36

Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation

Hoogland, A. I., Nelson, A. M., Gonzalez, B. D., Small, B. J., Breen, E. C., Sutton, S. K., Syrjala, K. L., Bower, J. E., Pidala, J., Booth‐Jones, M., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.008 · Cited by 36

Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients

Pagliardini, T., Castagna, L., Harbi, S., Porta, M. G. D., Rey, J., Fürst, S., Bramanti, S., Saillard, C., Legrand, F., Maisano, V., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.05.014 · Cited by 36

Hematopoietic Cell Transplant–Related Toxicities and Mortality in Frail Recipients

Pamukçuoğlu, M., Bhatia, S., Weisdorf, D. J., DeFor, T. E., Üstün, C., Nayar, M., Holtan, S. G., Jurdi, N.-E., Thyagarajan, B., Brunstein, C. G., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.07.030 · Cited by 36

Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation

Jamani, K., He, Q., Liu, Y., Davis, C., Hubbard, J. J., Schoch, G. H., Lee, S. J., Gooley, T. A., Flowers, M. E. D., & Cheng, G. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.12.002 · Cited by 36

Determination of fitness and therapeutic options in older patients with acute myeloid leukemia

Cortes, J. E., & Mehta, P. (2020) · American Journal of Hematology · doi:10.1002/ajh.26079 · Cited by 36

Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care

Kennedy, V. E., & Olin, R. L. (2021) · The Lancet Haematology · doi:10.1016/s2352-3026(21)00231-3 · Cited by 36

Comparison of Characteristics of Bacterial Bloodstream Infection between Adult Patients with Allogeneic and Autologous Hematopoietic Stem Cell Transplantation

Hong, J., Moon, S. M., Ahn, H. K., Sym, S. J., Park, Y. S., Park, J., Cho, Y. K., Cho, E. K., Shin, D. B., & Lee, J. H. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.03.019 · Cited by 36

Impact of Pretransplantation Risk Factors on Post Transplantation Outcome of Patients with Acute Myeloid Leukemia in Remission after Haploidentical Hematopoietic Stem Cell Transplantation

Wang, Y., Liu, D., Liu, K., Xu, L., Zhang, X., Han, W., Chen, H., Chen, Y., & Huang, X. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.10.002 · Cited by 36

Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First Allografts

Gyurkocza, B., Cao, T. M., Storb, R. F., Lange, T., Leisenring, W. M., Franke, G., Sorror, M. L., Hoppe, R. T., Maloney, D. G., Negrin, R. S., et al. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.06.011 · Cited by 36

Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection

Waghmare, A., Xie, H., Kuypers, J. M., Sorror, M. L., Jerome, K. R., Englund, J. A., Boeckh, M., & Leisenring, W. M. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.12.005 · Cited by 36

Renal failure in multiple myeloma: a medical emergency

Wirk, B. M. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.8 · Cited by 35

An Observational Study Using a National Administrative Database to Determine the Impact of Hospital Volume on Compliance With Clinical Practice Guidelines

Murata, A., Matsuda, S., Kuwabara, K., Fujino, Y., Kubo, T., Fujimori, K., & Horiguchi, H. (2011) · Medical Care · doi:10.1097/mlr.0b013e3182028954 · Cited by 35

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Kornblit, B. T., Maloney, D. G., Storer, B. E., Maris, M. B., Vindeløv, L. L., Hari, P., Langston, A. A., Pulsipher, M. A., Bethge, W. A., Chauncey, T. R., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.108340 · Cited by 35

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial

Kitko, C. L., Braun, T., Couriel, D. R., Choi, S. W., Connelly, J. A., Hoffmann, S., Goldstein, S. C., Magenau, J. M., Pawarode, A., Reddy, P. R., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.11.002 · Cited by 35

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT

Robinson, S. P., Boumendil, A., Finel, H., Schouten, H. C., Ehninger, G., Maertens, J. A., Crawley, C. R., Rambaldi, A., Russell, N. H., Anders, W., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw124 · Cited by 35

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

Battipaglia, G., Labopin, M., Candoni, A., Fanin, R., Cheikh, J. E., Blaise, D., Michallet, M., Ruggeri, A., Contentin, N., Ribera, J., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.302 · Cited by 35

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Mosna, F., Capelli, D., & Gottardi, M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6060057 · Cited by 35

Older Patients With Acute Myeloid Leukemia: Treatment Challenges and Future Directions.

Finn, L. E., Dalovisio, A. P., & Foran, J. M. (2017) · PubMed Central · Cited by 35

Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia

Xu, L.-P., Xu, Z., Wang, F.-R., Mo, X.-D., Han, T.-T., Han, W., Chen, Y.-H., Zhang, Y.-Y., Wang, J., Wang, Y., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.237 · Cited by 35

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality

Shouval, R., de Jong, C. N., Fein, J. A., Broers, A. E. C., Danylesko, I., Shimoni, A., Reurs, M. R., Baars, A. E., van der Schaft, N., Nagler, A., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.05.005 · Cited by 34

Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia

Loh, K. P., Tooze, J. A., Nicklas, B. J., Kritchevsky, S. B., Williamson, J. D., Ellis, L. R., Powell, B. L., Pardee, T. S., Goyal, N. G., & Klepin, H. D. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.03.014 · Cited by 35

The use of comprehensive geriatric assessment in older patients before allologeneic hematopoietic stem cell transplantation: A cross-sectional study

Rodrigues, M., de Souza, P. M. R., Koch, L. D. O. M., & Hamerschlak, N. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.05.022 · Cited by 35

Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients

Mishra, A., Bigam, K. D., Extermann, M., Faramand, R. G., Thomas, K., Pidala, J. A., & Baracos, V. E. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12604 · Cited by 35

The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L

Gamper, E., Cottone, F., Sommer, K., Norman, R., King, M. T., Breccia, M., Caocci, G., Patriarca, A., Palumbo, G. A., Stauder, R., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.03.015 · Cited by 35

Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation

Peña, M., Salas, M. Q., Mussetti, A., Moreno‐González, G., Bosch‐Vilaseca, A., Patiño, B., Jiménez, L., Kara, M., Parody, R., & Sureda, A. M. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004812 · Cited by 35

Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing

Damlaj, M., Alkhateeb, H. B., Hefazi, M., Partain, D. K., Hashmi, S. K., Gastineau, D. A., Al‐Kali, A., Wolf, R. C., Gangat, N., Litzow, M. R., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.04.026 · Cited by 35

Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial

Kornblit, B. T., Maloney, D. G., Storb, R. F., Storek, J., Hari, P., Vučinić, V., Maziarz, R. T., Chauncey, T. R., Pulsipher, M. A., Bruno, B., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.06.002 · Cited by 34

Graft-Versus-Host Disease Prophylaxis after Transplantation: A Network Meta-Analysis

Ziakas, P. D., Zervou, F. N., Zacharioudakis, I. M., & Mylonakis, E. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114735 · Cited by 34

Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact

Rieger, C. T., Wischumerski, I., Rust, C., & Fiegl, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145445 · Cited by 34

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation

Bejanyan, N., Rogosheske, J., DeFor, T. E., Lazaryan, A., Arora, M., Holtan, S. G., Jacobson, P. A., MacMillan, M. L., Verneris, M. R., Blazar, B. R., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.005 · Cited by 34

An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia

Shouval, R., Ruggeri, A., Labopin, M., Mohty, M., Sanz, G. F., Michel, G., Kuball, J. H. E., Chevallier, P., Al-Seraihy, A. S., Milpied, N. J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0489 · Cited by 35

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation

Pidala, J., Beato, F., Kim, J., Betts, B. C., Jim, H., Sagatys, E. M., Levine, J. E., Ferrara, J. L. M., Özbek, U., Ayala, E., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.171199 · Cited by 34

Patient‐based prediction algorithm of relapse after allo‐HSCT for acute Leukemia and its usefulness in the decision‐making process using a machine learning approach

Fuse, K., Uemura, S., Tamura, S., Suwabe, T., Katagiri, T., Tanaka, T. N., Ushiki, T., Shibasaki, Y., Sato, N., Yano, T., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2401 · Cited by 34

Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation

Pidala, J., Martens, M. J., Anasetti, C., Carreras, J., Horowitz, M. M., Lee, S. J., Antin, J. H., Cutler, C. S., & Logan, B. R. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2974 · Cited by 34

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma

Philippis, C. D., Legrand, F., Bramanti, S., Giordano, L., De, C. M., Duléry, R., Bouabdallah, R., Granata, A., Devillier, R., Mariotti, J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001336 · Cited by 34

Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials

Yassine, F., Iqbal, M., Murthy, H. S., Kharfan‐Dabaja, M. A., & Chávez, J. C. (2020) · Current Research in Translational Medicine · doi:10.1016/j.retram.2020.05.005 · Cited by 34

Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review

Laribi, K., Sobh, M., Ghez, D., & de Materre, A. B. (2021) · Annals of Hematology · doi:10.1007/s00277-020-04375-x · Cited by 34

Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes

Kim, Y., Waghmare, A., Xie, H., Holmberg, L., Pergam, S. A., Jerome, K. R., Leisenring, W. M., Ogimi, C., Campbell, A. P., Englund, J. A., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021004915 · Cited by 34

Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2

Michelis, F. V., Messner, H. A., Atenafu, E. G., McGillis, L., Lambie, A., Uhm, J., Alam, N., Seftel, M. D., Gupta, V. K., Kuruvilla, J. G., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.165 · Cited by 34

Long‐term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

Vaughn, J. E., Sorror, M. L., Storer, B. E., Chauncey, T. R., Pulsipher, M. A., Maziarz, R. T., Maris, M. B., Hari, P., Laport, G. G., Franke, G., et al. (2015) · Cancer · doi:10.1002/cncr.29498 · Cited by 34

Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over

Andorsky, D. J., Cohen, M., Naeim, A., & Pinter‐Brown, L. C. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.289 · Cited by 34

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin

Fujiwara, H., Maeda, Y., Sando, Y., Nakamura, M., Tani, K., Ishikawa, T., Nishimori, H., Matsuoka, K., Fujii, N., Kondo, E., et al. (2015) · Transfusion · doi:10.1111/trf.13437 · Cited by 34

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning

Sanghavi, K., Wiseman, A. C., Kirstein, M. N., Cao, Q., Brundage, R. C., Jensen, K., Rogosheske, J., Kurtzweil, A. J., Long-Boyle, J. R., Wagner, J. E., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.017 · Cited by 34

Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia

Rai, K. R. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0165-x · Cited by 33

Autologous hematopoietic stem cell transplantation in elderly patients (≥70years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study

Hermet, É., Cabrespine, A., Guièze, R., Garnier, A., Tempescul, A., Lenain, P., Bouabdallah, R., Vilque, J., Frayfer, J., Bordessoule, D., et al. (2015) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2015.04.005 · Cited by 33

Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS

Sharma, A., Kayal, S., Iqbal, S., Malik, P. S., & Raina, V. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-489 · Cited by 33

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes

Getta, B. M., Kishtagari, A., Hilden, P. D., Tallman, M. S., Maloy, M., Gonzales, P. K., Castro-Malaspina, H. R., Perales, M., Giralt, S., Tamari, R., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.03.020 · Cited by 35

High‐dose melphalan‐based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia

Steckel, N. K., Groth, C., Mikesch, J., Trenschel, R., Ottinger, H. D., Kordelas, L., Müller‐Tidow, C., Schliemann, C., Reicherts, C., Albring, J. C., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15137 · Cited by 33

Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients

Fauer, A. J., Hoodin, F., LaLonde, L., Errickson, J., Runaas, L., Churay, T. L., Seyedsalehi, S., Warfield, C., Chappell, G., Brookshire, K., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4450-4 · Cited by 32

Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

Nykolyszyn, C., Granata, A., Pagliardini, T., Castagna, L., Harbi, S., Bouabdallah, R., Vey, N., Fürst, S., Maisano, V., Legrand, F., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0682-2 · Cited by 33

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study

Pasvolsky, O., Shimony, S. O., Ram, R., Shimoni, A., Shargian, L., Avni, B. R., Wolach, O., Shochat, T., Yerushalmi, R., Amit, O., et al. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04693-8 · Cited by 33

Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis

Wood, A. C., Perez, A. P., Arciola, B., Patel, K., Johnson, G., DiMaggio, E. C., Bachmeier, C. A., Reid, K. M., Corallo, S. A., Vargas, M. H., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.09.009 · Cited by 34

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis

Castagna, L., Mussetti, A., Devillier, R., Dominietto, A., Marcatti, M., Milone, G., Maura, F., Philippis, C. D., Bruno, B., Fürst, S., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.05.006 · Cited by 33

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease

Akahoshi, Y., Kimura, S., Tada, Y., Matsukawa, T., Tamaki, M., Doki, N., Uchida, N., Tanaka, M., Nakamae, H., Kuriyama, T., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005885 · Cited by 32

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB

Clerici, D. T., Galli, L., Greco, R., Lugli, A. P., Erbella, F., Ripa, M., Din, C. T., Nitti, R., Giglio, F., Mastaglio, S., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008226 · Cited by 33

A Prospective Study Comparing the Outcomes and Health-Related Quality of Life in Adult Patients with Myeloid Malignancies Undergoing Allogeneic Transplantation Using Myeloablative or Reduced-Intensity Conditioning

Gupta, V. K., Panzarella, T., Li, L., Khan, J., Sharma, A., Lipton, J. H., Kuruvilla, J. G., Messner, H. A., & Alibhai, S. M. H. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.05.022 · Cited by 32

Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia

Đjunić, I., Virijević, M., Novković, A., Djurasinovic, V., Čolović, N., Vidović, A., Suvajdžić, N., & Tomin, D. (2012) · Hematology · doi:10.1179/102453312x13221316477651 · Cited by 32

Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning

Shanavas, M., Messner, H. A., Atenafu, E. G., Kim, D. H., Kuruvilla, J. G., Lipton, J. H., Uhm, J., Seftel, M. D., Alam, N., & Gupta, V. K. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.131 · Cited by 32

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

Ustun, C., Wiseman, A. C., DeFor, T. E., Yohe, S. L., Linden, M. A., Oran, B., Burke, M. J., Warlick, E. D., Miller, J. S., & Weisdorf, D. J. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.124 · Cited by 32

Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation

Arai, Y., Kanda, J., Nakasone, H., Kondo, T., Uchida, N., Fukuda, T., Ohashi, K., Kaida, K., Iwato, K., Eto, T., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.205 · Cited by 32

Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia

Solomon, S. R., Sizemore, C. A., Zhang, X., Brown, S. L., Holland, H. K., Morris, L. E., Solh, M., & Bashey, A. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.07.010 · Cited by 32

Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial

Knight, J. M., Syrjala, K. L., Majhail, N. S., Martens, M. J., Le‐Rademacher, J. G., Logan, B. R., Lee, S. J., Jacobsen, P. B., Wood, W. A., Jim, H., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.016 · Cited by 32

The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients

Hoogland, A. I., Nelson, A. M., Small, B. J., Hyland, K. A., Gonzalez, B. D., Booth‐Jones, M., Anasetti, C., Jacobsen, P. B., & Jim, H. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.08.006 · Cited by 32

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma

Shah, N. D., Cornelison, A. M., Saliba, R. M., Ahmed, S., Nieto, Y. L., Bashir, Q., Parmar, S., Hosing, C. M., Popat, U., Shpall, E. J., et al. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12970 · Cited by 32

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

Shah, N. N., Ahn, K. W., Litovich, C., Fenske, T. S., Ahmed, S., Battiwalla, M., Bejanyan, N., Dahi, P. B., Bolaños‐Meade, J., Chen, A. I., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018018531 · Cited by 32

Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients

Ogimi, C., Krantz, E. M., Golob, J. L., Waghmare, A., Liu, C., Leisenring, W. M., Woodard, C., Marquis, S. R., Kuypers, J. M., Jerome, K. R., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.05.016 · Cited by 32

Promoting Health and Well-Being Through Mobile Health Technology (Roadmap 2.0) in Family Caregivers and Patients Undergoing Hematopoietic Stem Cell Transplantation: Protocol for the Development of a Mobile Randomized Controlled Trial

Rozwadowski, M., Dittakavi, M., Mazzoli, A., Hassett, A. L., Braun, T., Barton, D. L., Carlozzi, N. E., Sen, S., Tewari, M., Hanauer, D. A., et al. (2020) · JMIR Research Protocols · doi:10.2196/19288 · Cited by 29

Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults

Mishra, A., Preussler, J. M., Bhatt, V. R., Bredeson, C., Chhabra, S., D’Souza, A., Dahi, P. B., Hacker, E. D., Gowda, L., Hashmi, S. K., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.03.028 · Cited by 32

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes

Oran, B., Ahn, K. W., Fretham, C., Beitinjaneh, A., Bashey, A., Pawarode, A., Wirk, B. M., Scott, B. L., Savani, B. N., Bredeson, C., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.08.007 · Cited by 33

GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms

Malagola, M., Polverelli, N., Rubini, V., Martino, M. V., Patriarca, F., Bruno, B., Giaccone, L., Grillo, G., Bramanti, S., BERNASCONI, P. P., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.11.006 · Cited by 32

Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience

Busca, A., Cinatti, N., Gill, J., Passera, R., Dellacasa, C. M., Giaccone, L., Dogliotti, I., Manetta, S., Corcione, S., & Rosa, F. G. D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.805514 · Cited by 32

Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation

Duléry, R., Malard, F., Brissot, É., Banet, A., Sestili, S., Belhocine, R., Calabrò, M., de Wyngaert, Z. V., Bonnin, A., Ledraa, T., et al. (2023) · Bone Marrow Transplantation · doi:10.1038/s41409-023-02085-2 · Cited by 32

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity

Lee, J.-H., Lee, J.-H., Lim, S.-N., Kim, D., Kim, S. H., Lee, Y. S., Kang, Y.-A., Kang, S.-I., Jeon, M. J., Seol, M., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.190 · Cited by 32

Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study

Kataoka, K., Nannya, Y., Ueda, K., Kumano, K., Takahashi, T., & Kurokawa, M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.194 · Cited by 32

Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL

Mizuta, S., Matsuo, K., Maeda, T., Yujiri, T., Hatta, Y., Kimura, Y. J., Ueda, Y., Kanamori, H., Usui, N., Akiyama, H., et al. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2012.18 · Cited by 32

How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT

Fuji, S., Rovó, A., Ohashi, K., Griffith, M., Einsele, H., Kapp, M., Mohty, M., Majhail, N. S., Engelhardt, B. G., Tichelli, A., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.81 · Cited by 33

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia

Lipof, J. J., Loh, K. P., O’Dwyer, K. M., & Liesveld, J. (2018) · Cancers · doi:10.3390/cancers10060179 · Cited by 32

Comparable Antileukemia/Lymphoma Effects in Nonremission Patients Undergoing Allogeneic Hematopoietic Cell Transplantation with a Conventional Cytoreductive or Reduced-Intensity Regimen

Maruyama, D., Fukuda, T., Kato, R., Yamasaki, S., Usui, E., Morita‐Hoshi, Y., Kim, S.-W., Mori, S., Heike, Y., Makimoto, A., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.04.004 · Cited by 32

Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future

Choi, J., Shukla, M., & Abdul‐Hay, M. (2023) · Acta Haematologica · doi:10.1159/000531628 · Cited by 34

Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders

Kwon, M., Balsalobre, P., Serrano, D., Pérez‐Corral, A. M., Buño, I., Anguita, J., Gayoso, J., & Díez-Martín, J. L. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.08.019 · Cited by 31

TRANSPLANTATION Hematopoietic cell transplantation (HCT)–specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Sorror, M. L., Maris, M. B., Storb, R. F., Baron, F., S, B. M., Maloney, D. G., & Storer, B. E. (2016)

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights

Sorror, M. L., Storer, B. E., & Storb, R. F. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.131 · Cited by 9

54: Hematopoietic cell transplantation-comorbidity index (HCT-CI)

Kassar, M., Shell, K., Gregory, S. A., Venugopal, P., Shammo, J. M., & Fung, H. C. H. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.12.057

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Kato, R., Fukuda, T., Usui, E., Yamasaki, S., Maruyama, D., Morita, Y., Kim, S., Mori, S., Tanosaki, R., Tajima, K., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2731.2731 · Cited by 1

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.004 · Cited by 222